TwitchView® Train of Four Monitor Used to Eliminate Residual Neuromuscular Blockade
ASA guideline first author Dr. Stephan Thilen et al. reports exciting results from a protocol that completely eliminated post-operative residual neuromuscular blockade (PRNMB). Of note, Thilen et al. achieved this groundbreaking advance in patient safety using the TwitchView® Train of Four (TOF) monitor while maintaining a role for neostigmine as a reversal strategy, resulting in pharmacologic cost savings of $42 per patient. - May 30, 2023
Blink Device Company Announces Launch of GelAuto™ Wearable Hand Gel System
Blink Device Company launches the GelAuto™ wearable smart hand gel system. The Gelauto is an app controlled system that allows users to control gel volume, set reminders and track gel frequency of single users and groups. - September 22, 2020
New Study Confirms TwitchView® Quantitative Monitor for Neuromuscular Blockade is Comparable to Gold Standard Mechanomyography
Blink Device Company announced today that a study comparing the TwitchView® quantitative train-of-four (TOF) electromyography-based monitor to accelerometry and mechanomyography has been published in the journal Anaesthesia (https://onlinelibrary.wiley.com/doi/10.1111/anae.14872). The results... - October 18, 2019
Blink Device Company Announces TwitchView™ Quantitative Monitor for Neuromuscular Blockade is Now Compatible with Major Electronic Medical Records
Blink Device Company announced today that the TwitchView™ quantitative train-of-four (TOF) monitor now integrates with most major electronic medical records (EMR). Commercially available in the United States, Europe, and South Korea, the TwitchView™ neuromuscular TOF monitor uses... - June 04, 2019
Blink Device Company Launches TwitchView™ Neuromuscular TOF Monitor at American Society of Anesthesiologists Annual Meeting
Presents Clinical Validation Data Establishing Equivalence to Gold Standard - October 10, 2018
Medical Device Manufacturer Blink Device Company Signs Distribution Agreement with KCPMED
KCPMED Appointed Exclusive South Korean Distributor for TwitchView™ Neuromuscular Monitor. - September 05, 2018
Blink Device Company Receives CE Mark for TwitchView™ Quantitative Monitor for Neuromuscular Blockade; Debuts at European Society of Anaesthesiology Meeting
Blink Device Company announced today that it has received a CE Mark for TwitchView, its novel, user-friendly, quantitative monitor for neuromuscular blockade. With this certification, the company plans to launch the product into the European market, first appearing at the 2018 European Society of... - June 01, 2018
Medical Device Startup Blink Device Company Announces 510(k) Clearance of TwitchView Quantitative Monitor for Neuromuscular Blockade and Hires VP of Sales and Marketing
Blink Device Company, a recently formed medical device company helmed by industry veterans, aims to support clinicians with practical, cutting-edge technologies and never-before-seen reliability. Their recently 510(k) cleared product, TwitchView, is an objective monitor for neuromuscular blockade,... - April 26, 2018